Open-Label Trial on the Effects of Memantine in Adults With Obsessive-Compulsive Disorder After a Single Ketamine Infusion

Volume: 77, Issue: 05, Pages: 688 - 689
Published: May 25, 2016
Abstract
Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.To the Editor: The only first-line pharmacologic treatments recommended for obsessive-compulsive disorder (OCD) are serotonin reuptake inhibitors (SRIs). We found that a single intravenous (IV) dose of ketamine, an N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, rapidly decreases symptoms in...
Paper Details
Title
Open-Label Trial on the Effects of Memantine in Adults With Obsessive-Compulsive Disorder After a Single Ketamine Infusion
Published Date
May 25, 2016
Volume
77
Issue
05
Pages
688 - 689
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.